SCHEMBL2786485

SCHEMBL2786485

C1CC2CCC1CC21COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5599602 0.85
SCHEMBL31579278 0.78
SCHEMBL31493486 0.70
SCHEMBL22193940 0.65
SCHEMBL3551149 0.65 GRIN2D (0.40)
SCHEMBL11081114 0.64 CHRM1 (0.33)
SCHEMBL22193941 0.61 PKM (0.31)
SCHEMBL11759566 0.60 HTR2A (0.33)
SCHEMBL8081901 0.59
SCHEMBL3423164 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2218715-B1 PHOTOACID GENERATOR AND PHOTOREACTIVE COMPOSITION SUMITOMO SEIKA CHEMICALS (JP) 2017-06-28 EP disclosed
US-8216768-B2 Photoacid generator and photoreactive composition SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2012-07-10 US disclosed
US-20100233621-A1 PHOTOACID GENERATOR AND PHOTOREACTIVE COMPOSITION SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2010-09-16 US disclosed
EP-2218715-A1 PHOTOACID GENERATOR AND PHOTOREACTIVE COMPOSITION Sumitomo Seika Chemicals CO. LTD. (JP) 2010-08-18 EP disclosed
EP-1846354-B1 SUBSTITUTED CYCLOPENTANES OR CYCLOPENTANONES FOR THE TREATMENT OF OCULAR HYPERTENSIVE CONDITIONS ALLERGAN INC (US) 2010-04-28 EP disclosed
US-7405240-B2 Substituted cyclopentanes or cyclopentanones as therapeutic agents ALLERGAN, INC. (US) 2008-07-29 US disclosed
US-20080119560-A1 SUBSTITUTED CYCLOPENTANES OR CYCLOPENTANONES AS THERAPEUTIC AGENTS ALLERGAN, INC. 2008-05-22 US disclosed
US-7323591-B2 Substituted cyclopentanes or cyclopentanones as therapeutic agents ALLERGAN, INC. (US) 2008-01-29 US disclosed
US-20070265464-A1 SUBSTITUTED CYCLOPENTANES OR CYCLOPENTANONES AS THERAPEUTIC AGENTS OLD DAVID W 2007-11-15 US disclosed
EP-1846354-A2 SUBSTITUTED CYCLOPENTANES OR CYCLOPENTANONES FOR THE TREATMENT OF OCULAR HYPERTENSIVE CONDITIONS Allergan, Inc. (US) 2007-10-24 EP disclosed
EP-1237983-B1 POLYMERIZABLE COMPOSITION, CURED MATERIAL THEREOF AND METHOD FOR MANUFACTURING THE SAME SHOWA DENKO KK (JP) 2007-08-01 EP disclosed
WO-2006076370-A2 SUBSTITUTED CYCLOPENTANES OR CYCLOPENTANONES FOR THE TREATMENT OF OCULAR HYPERTENSIVE CONDITIONS ALLERGAN, INC. (US) 2006-07-20 WO disclosed
US-6783840-B2 FOR PRODUCING PRINTED CIRCUIT BOARD SHOWA DENKO K.K. (JP) 2004-08-31 US disclosed
US-20030022958-A1 Resist ink composition SHOWA DENKO K.K. (JP) 2003-01-30 US disclosed
US-20020161068-A1 Polymerizable composition, cured material thereof and method for manufacturing the same SHOWA DENKO K.K. (JP) 2002-10-31 US disclosed